Fuhong He
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Unraveling cellular and molecular mechanisms of relapse in CD19/CD22 dual-targeting chimeric antigen receptor T-cell therapy for B-cell acute lymphoblastic leukemia.
Journal: Leukemia
Published: September 30, 2025
Biomedical Big Data and Artificial Intelligence in Blood.
Journal: Genomics, proteomics & bioinformatics
Published: April 30, 2025
Analyses of Long Noncoding RNA and mRNA Profiles in Subjects with the Phlegm-Dampness Constitution.
Journal: BioMed research international
Published: April 15, 2021
Ecological principle meets cancer treatment: treating children with acute myeloid leukemia with low-dose chemotherapy.
Journal: National science review
Published: November 11, 2018
Benzene metabolite hydroquinone promotes DNA homologous recombination repair via the NF-κB pathway.
Journal: Carcinogenesis
Published: June 29, 2018
Chromatin regulator Asxl1 loss and Nf1 haploinsufficiency cooperate to accelerate myeloid malignancy.
Journal: The Journal of clinical investigation
Published: March 28, 2018
PDGFRB mutation and tyrosine kinase inhibitor resistance in Ph-like acute lymphoblastic leukemia.
Journal: Blood
Published: November 20, 2017
Loss of Asxl2 leads to myeloid malignancies in mice.
Journal: Nature communications
Published: August 18, 2016
Loss of Asxl1 Alters Self-Renewal and Cell Fate of Bone Marrow Stromal Cell, Leading to Bohring-Opitz-like Syndrome in Mice.
Journal: Stem cell reports
Published: January 26, 2016
Rictor/mammalian target of rapamycin 2 regulates the development of Notch1 induced murine T-cell acute lymphoblastic leukemia via forkhead box O3.
Journal: Experimental hematology
Published: April 21, 2014
Last Updated: 09/26/2026